Plegridy Observational Program
Public ClinicalTrials.gov record NCT02230969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Plegridy™ (Peginterferon β-1a) Real World Effectiveness and Safety Observational Program
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objectives of the study are to determine the incidence of serious adverse events (SAEs) in participants with relapsing forms of multiple sclerosis (MS) in routine clinical practice and to assess the overall long-term clinical effectiveness of Plegridy in participants with relapsing forms of MS in routine clinical practice. The secondary objectives of this study in this study population are to describe Plegridy prescription and utilization adherence patterns in routine clinical practice; to assess the specific long-term clinical effectiveness of Plegridy in participants with relapsing forms of MS in routine clinical practice; to monitor the safety and tolerability of Plegridy in routine clinical practice by assessing the incidence of adverse events (AEs) of flu-like symptoms (FLS), injection site reactions (ISRs), and AEs (including laboratory abnormalities) leading to treatment discontinuation; to assess the effect of FLS on participant-reported effectiveness of, and satisfaction with, prophylactic management using a FLS-Visual Analog Scale (FLS-VAS); to evaluate the change in health-related quality of life (HRQoL), FLS, FLS-VAS, healthcare resource consumption, and treatment adherence over time.
Study identification
- NCT ID
- NCT02230969
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,208 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2014 (Actual)
- Primary completion
- Jan 20, 2022 (Actual)
- Completion
- Jan 20, 2022 (Actual)
- Last update posted
- Sep 26, 2022
2014 – 2022
United States locations
- U.S. sites
- 50
- U.S. states
- 33
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Homewood | Alabama | 35209 | — |
| Research Site | Gilbert | Arizona | 85234 | — |
| Research Site | Scottsdale | Arizona | 85258 | — |
| Research Site | Berkeley | California | 94705 | — |
| Research Site | California City | California | 93449 | — |
| Research Site | Hanford | California | 93230 | — |
| Research Site | Orange | California | 92868 | — |
| Research Site | Basalt | Colorado | 81621 | — |
| Research Site | Colorado Springs | Colorado | 80907 | — |
| Research Site | Washington D.C. | District of Columbia | 20007 | — |
| Research Site | Washington D.C. | District of Columbia | 20037 | — |
| Research Site | Delray Beach | Florida | 33445 | — |
| Research Site | Atlanta | Georgia | 30327 | — |
| Research Site | Schaumburg | Illinois | 60173 | — |
| Research Site | Indianapolis | Indiana | 46256 | — |
| Research Site | Des Moines | Iowa | 50314 | — |
| Research Site | Iowa City | Iowa | 52242 | — |
| Research Site | Louisville | Kentucky | 40207 | — |
| Research Site | New Orleans | Louisiana | 70121 | — |
| Research Site | Scarborough | Maine | 04074 | — |
| Research Site | Boston | Massachusetts | 02215 | — |
| Research Site | Lexington | Massachusetts | 02421 | — |
| Research Site | Worcester | Massachusetts | 01655 | — |
| Research Site | Southfield | Michigan | 48034 | — |
| Research Site | Golden Valley | Minnesota | 55422 | — |
| Research Site | St Louis | Missouri | 63131 | — |
| Research Site | Great Falls | Montana | 59405 | — |
| Research Site | Lebanon | New Hampshire | 03756 | — |
| Research Site | Freehold | New Jersey | 07728 | — |
| Research Site | Albuquerque | New Mexico | 87131 | — |
| Research Site | Buffalo | New York | 14203 | — |
| Research Site | New Hyde Park | New York | 11042 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | Staten Island | New York | 10306 | — |
| Research Site | Charlotte | North Carolina | 28203 | — |
| Research Site | Hickory | North Carolina | 28602 | — |
| Research Site | Raleigh | North Carolina | 27607 | — |
| Research Site | Dayton | Ohio | 45417 | — |
| Research Site | Dayton | Ohio | 45459 | — |
| Research Site | Oklahoma City | Oklahoma | 73104 | — |
| Research Site | Oklahoma City | Oklahoma | 73112 | — |
| Research Site | Portland | Oregon | 97225 | — |
| Research Site | Pittsburgh | Pennsylvania | 15212 | — |
| Research Site | Port Royal | South Carolina | 29935 | — |
| Research Site | Knoxville | Tennessee | 37934 | — |
| Research Site | Bedford | Texas | 76021 | — |
| Research Site | Salt Lake City | Utah | 84103 | — |
| Research Site | Richmond | Virginia | 23298 | — |
| Research Site | Virginia Beach | Virginia | 23456 | — |
| Research Site | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02230969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 26, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02230969 live on ClinicalTrials.gov.